(Q46378593)

21 December 2017

title

alpha-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors (English)

1 reference

21 December 2017

author

Carlotta Granchi

5

1 reference

21 December 2017

Filippo Minutolo

6

1 reference

21 December 2017

Simona Rapposelli

7

1 reference

21 December 2017

Stefano Moro

9

1 reference

21 December 2017

Maria Digiacomo

Maria Digiacomo

4

0 references

Simone Bertini

Simone Bertini

3

0 references

Elisa Ghilardi

2

Elisa Ghilardi

1 reference

21 December 2017

Valentina Asso

1

Valentina Asso

1 reference

21 December 2017

Andrea Bortolato

8

Andrea Bortolato

1 reference

21 December 2017

author name string

Marco Macchia

10

1 reference

21 December 2017

publication date

1 October 2008

1 reference

21 December 2017

published in

ChemMedChem

1 reference

21 December 2017

volume

3

1 reference

21 December 2017

issue

10

1 reference

21 December 2017

page(s)

1530-1534

1 reference

21 December 2017

In silico prediction models for blood-brain barrier permeation

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Human β-Secretase (BACE) and BACE Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

A continuous time-resolved fluorescence assay for identification of BACE1 inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Apo and inhibitor complex structures of BACE (beta-secretase).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Ensemble-docking approach on BACE-1: pharmacophore perception and guidelines for drug design

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Novel procedure for modeling ligand/receptor induced fit effects.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

In silico multi-filter screening approaches for developing novel beta-secretase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Diverse, high-quality test set for the validation of protein-ligand docking performance.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800162

7 January 2021

Identifiers

DOI

10.1002/CMDC.200800162

1 reference

21 December 2017

1 reference

21 December 2017